Fedha

Hisa unazofuatilia
KVUE:NYSE
Kenvue Inc
US$ 18.01
+1.41%
(+0.25) Siku 1
US$ 18.01
0.00% (0.00)
Baada ya saa
Imefungwa: 14 Okt, 16:00:05 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya KVUE...
Fungua
US$ 17.92
Juu
US$ 18.04
Chini
US$ 17.76
Mtaji wa soko
34.59B
Wastani wa kiasi cha mauzo
24.20M
Kiasi cha mauzo ya hisa
0.00
Gawio
4.66%
Mgawo wa faida wa kila robo mwaka
US$ 0.21
Tarehe ya kutojumuisha gawio
21 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
20.88
Juu kwa wiki 52
US$ 20.13
Chini kwa wiki 52
US$ 14.02
EPS
US$ 0.86
Beta
0.48
Hisa za wawekezaji
1.92B
Idadi ya wafanyakazi
elfu 22
Fungua
US$ 17.92
Juu
US$ 18.04
Chini
US$ 17.76
Mtaji wa soko
34.59B
Wastani wa kiasi cha mauzo
24.20M
Kiasi cha mauzo ya hisa
0.00
Gawio
4.66%
Mgawo wa faida wa kila robo mwaka
US$ 0.21
Tarehe ya kutojumuisha gawio
21 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
20.88
Juu kwa wiki 52
US$ 20.13
Chini kwa wiki 52
US$ 14.02
EPS
US$ 0.86
Beta
0.48
Hisa za wawekezaji
1.92B
Idadi ya wafanyakazi
elfu 22
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Kuhusu Kenvue Inc
Afisa Mkuu Mtendaji (CEO)Kirk Perry
Wafanyakazielfu 21.9
Lilianzishwa2022
Makao makuuSummit, New Jersey, Marekani
SektaPersonal care products
Tovutikenvue.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 7 waliotoa ukadiriaji wa hisa kwa KVUE katika miezi 3 iliyopita
Shikilia
Nunua
1
Shikilia
6
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 7 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya KVUE katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 18.01
US$ 20.00 (+11.05%)
Wastani
US$ 19.25 (+6.89%)
Chini kabisa
US$ 19.00 (+5.50%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Filippo Falorni
Citi
Hold
Maintained
US$ 19.00
+5.5%
10/14/2026
Susan Anderson
Canaccord Genuity
Buy
Maintained
-
-
09/16/2026
Taylor Conrad
Argus Research
Hold
Maintained
-
-
09/14/2026
Peter Grom
UBS
Hold
Maintained
US$ 19.00
+5.5%
08/11/2026
Nik Modi
RBC Capital
Hold
Maintained
US$ 20.00
+11%
08/07/2026
Jon Andersen
William Blair
Hold
Maintained
-
-
08/06/2026
Lauren Lieberman
Barclays
Hold
Maintained
US$ 19.00
+5.5%
08/06/2026
Javier Escalante
Evercore ISI
Hold
Maintained
US$ 18.00
-0.1%
02/18/2026
Keith Devas
Jefferies
Hold
Downgraded
US$ 18.00
-0.1%
01/30/2026
Ripoti ya mwisho
6 Ago 2026
Kipindi cha Kifedha
Robo2 2026
US$ 0.31 / US$ 0.32
-2.82%hujafikia
Mapato dhidi ya makadirio (USD)
3.96B / 3.97B
-0.36%hujafikia
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
3.76B
3.78B
3.91B
3.96B
Gharama ya bidhaa zilizouzwa
1.53B
1.63B
1.60B
1.64B
Gharama ya mapato
1.53B
1.63B
1.60B
1.64B
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.51B
1.51B
1.45B
1.54B
Gharama ya uendeshaji
1.51B
1.48B
1.46B
1.54B
Jumla ya gharama za uendeshaji
3.04B
3.11B
3.06B
3.19B
Mapato ya uendeshaji
726.00M
674.00M
845.00M
768.00M
Mapato mengine yasiyo ya uendeshaji
10.00M
7.00M
-
1.00M
EBT ikijumuisha vipengee visivyo vya kawaida
526.00M
427.00M
672.00M
598.00M
EBT bila kujumuisha vipengee visivyo vya kawaida
623.00M
574.00M
750.00M
667.00M
Gharama ya kodi ya mapato
128.00M
97.00M
198.00M
142.00M
Kiwango cha kodi kinachotumika
24.33%
22.72%
29.46%
23.75%
Gharama nyingine za uendeshaji
1.00M
-30.00M
11.00M
6.00M
Mapato halisi
398.00M
330.00M
474.00M
456.00M
Kiwango cha faida halisi
10.57%
8.73%
12.13%
11.53%
Mapato kwa kila hisa
0.28
0.27
0.32
0.31
Mapato ya riba na uwekezaji
14.00M
11.00M
11.00M
13.00M
Gharama ya riba
-107.00M
-109.00M
-106.00M
-103.00M
Jumla ya gharama halisi za riba
-93.00M
-98.00M
-95.00M
-90.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
867.00M
713.00M
988.00M
913.00M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google